Cargando…

Structurally Related Kappa Opioid Receptor Agonists with Substantial Differential Signaling Bias: Neuroendocrine and Behavioral Effects in C57BL6 Mice

BACKGROUND: The kappa opioid receptor system has been revealed as a potential pharmacotherapeutic target for the treatment of addictions to substances of abuse. Kappa opioid receptor agonists have been shown to block the rewarding and dopamine-releasing effects of psychostimulants. Recent investigat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dunn, Amelia D, Reed, Brian, Guariglia, Catherine, Dunn, Alexandra M, Hillman, Joshua M, Kreek, Mary Jeanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Regular Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119295/ https://www.ncbi.nlm.nih.gov/pubmed/29635340 http://dx.doi.org/10.1093/ijnp/pyy034

Ejemplares similares

Characterization of Pyrrolidinyl-hexahydro-pyranopiperazines as a Novel Kappa Opioid Receptor Agonist Scaffold
por: Reed, Brian, et al.
Publicado: (2022)

Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
por: Butelman, Eduardo R., et al.
Publicado: (2015)

Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
por: Butelman, Eduardo R., et al.
Publicado: (2015)

Therapeutic Potential of Kappa Opioid Agonists
por: Beck, Tyler C., et al.
Publicado: (2019)

Aticaprant (Clinically Developed Kappa-Opioid Receptor Antagonist) Combined With Naltrexone Prevents Alcohol “Relapse” Drinking
por: Zhou, Y, et al.
Publicado: (2022)

Molecular mechanism of biased signaling at the kappa opioid receptor
por: El Daibani, Amal, et al.
Publicado: (2023)

Opioids, dopamine, stress, and the addictions
por: Kreek, Mary Jeanne
Publicado: (2007)

Orvinols with Mixed Kappa/Mu Opioid Receptor Agonist Activity
por: Greedy, Benjamin M., et al.
Publicado: (2013)

Behavioral Pharmacology of Novel Kappa Opioid Receptor Antagonists in Rats
por: Page, Sarah, et al.
Publicado: (2019)

Stress-Induced Enhancement of Ethanol Intake in C57BL/6J Mice with a History of Chronic Ethanol Exposure: Involvement of Kappa Opioid Receptors
por: Anderson, Rachel I., et al.
Publicado: (2016)

Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence
por: Reed, Brian, et al.
Publicado: (2018)

Behavioral architecture of opioid reward and aversion in C57BL/6 substrains
por: Kirkpatrick, Stacey L., et al.
Publicado: (2015)

Effects of mu- and kappa-2 opioid receptor agonists on pain and rearing behaviors
por: Neubert, John K, et al.
Publicado: (2007)

Novel Kappa-Opioid Receptor Agonist for the Treatment of Cholestatic Pruritus: Systematic Review
por: Bailey, Adrian Joseph Michel, et al.
Publicado: (2022)

The Kappa Opioid Receptor and the Sleep of Reason: Cortico-Subcortical Imbalance Following Salvinorin-A
por: Ona, Genís, et al.
Publicado: (2021)

nor-BNI Antagonism of Kappa Opioid Agonist-Induced Reinstatement of Ethanol-Seeking Behavior
por: Harshberger, Erin, et al.
Publicado: (2016)

Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation
por: Shokirova, Hurramhon, et al.
Publicado: (2021)

Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL/KalwRij mouse
por: Vanderkerken, K, et al.
Publicado: (2000)

A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
por: Mores, Kendall L., et al.
Publicado: (2019)

A single, extinction-based treatment with a kappa opioid receptor agonist elicits a long-term reduction in cocaine relapse
por: Heinsbroek, Jasper A., et al.
Publicado: (2018)

Diuretic Activity of a Novel Peripherally-Restricted Orally-Active Kappa Opioid Receptor Agonist
por: Beck, Tyler C., et al.
Publicado: (2019)

Antipruritic Effect of Nalbuphine, a Kappa Opioid Receptor Agonist, in Mice: A Pan Antipruritic
por: Inan, Saadet, et al.
Publicado: (2021)

Current Paranoid Thinking in Patients With Delusions: The Presence of Cognitive-Affective Biases
por: Freeman, Daniel, et al.
Publicado: (2013)

Current status of opioid addiction treatment and related preclinical research
por: Kreek, M. J., et al.
Publicado: (2019)

The Periodontium Damage Induces Neuronal Cell Death in the Trigeminal Mesencephalic Nucleus and Neurodegeneration in the Trigeminal Motor Nucleus in C57BL/6J Mice
por: Dhar, Ashis, et al.
Publicado: (2021)

Responses to ethanol in C57BL/6 versus C57BL/6 × 129 hybrid mice
por: Lim, Jana P, et al.
Publicado: (2012)

Pharmacological profiles of opioid ligands at Kappa opioid receptors
por: Gharagozlou, Parham, et al.
Publicado: (2006)

Development of a Peptide-Derived Orally-Active Kappa-Opioid Receptor Agonist Targeting Peripheral Pain
por: Hughes, Jr, Francis M., et al.
Publicado: (2013)

Evaluation of the abuse potential of difelikefalin, a selective kappa‐opioid receptor agonist, in recreational polydrug users
por: Shram, Megan J., et al.
Publicado: (2021)

Sex Differences in Kappa Opioid Receptor Agonist Mediated Attenuation of Chemotherapy-Induced Neuropathic Pain in Mice
por: Paton, Kelly F., et al.
Publicado: (2022)

Mechanisms of Kappa Opioid Receptor Potentiation of Dopamine D2 Receptor Function in Quinpirole-Induced Locomotor Sensitization in Rats
por: Escobar, Angélica P, et al.
Publicado: (2017)

Unexpected effects of the MIP‐Cre(ER) transgene and tamoxifen on β‐cell growth in C57Bl6/J male mice
por: Carboneau, Bethany A., et al.
Publicado: (2016)

A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains
por: Simon, Michelle M, et al.
Publicado: (2013)

Synthesis and Evaluation of Novel Biased μ-Opioid-Receptor (μOR) Agonists
por: Ma, Mengjun, et al.
Publicado: (2019)

Cardioprotection by kappa-opioid receptor agonist U50488H is mediated by opioidergic regulation but not by calcium current modulation
por: Chun, Kook Jin, et al.
Publicado: (2010)

The Differential Effects of a Selective Kappa-Opioid Receptor Agonist, U50488, in Guinea Pig Heart Tissues
por: Hung, Chi-Feng, et al.
Publicado: (2015)

Agonist-Promoted Phosphorylation and Internalization of the Kappa Opioid Receptor in Mouse Brains: Lack of Connection With Conditioned Place Aversion
por: Chen, Chongguang, et al.
Publicado: (2022)

Discovery of 7-Azanorbornane-Based Dual Agonists for the Delta and Kappa Opioid Receptors through an In Situ Screening Protocol
por: Karaki, Fumika, et al.
Publicado: (2023)

Similar responsiveness between C57BL/6N and C57BL/6J mouse substrains to superovulation
por: Shindo, Miyuki, et al.
Publicado: (2021)

Restricted kappa chain expression in early ontogeny: biased utilization of V kappa exons and preferential V kappa-J kappa recombinations
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_r3pdlb38t9k1mot4epaf9t06g6